Diabetes Mellitus Clinical Trial
Official title:
Effects of a Physical Exercise Program Among Diabetic Women Users of the National Health System: a Randomized Clinical Trial
| Verified date | August 2017 |
| Source | Federal University of Pelotas |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The study aims at evaluating the effects of an intervention among diabetic women (40 years or older) who belong to the Basic Health Units System (Brazilian public health system). The novelty of this project is that the intervention is low cost and demands very little from the health system in terms of structure, facilities and personnel.
| Status | Completed |
| Enrollment | 120 |
| Est. completion date | July 2017 |
| Est. primary completion date | March 2017 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 40 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - females; - type 2 diabetic; - diagnosed for more than one year; - BMI =25 kg / m²; - age between 40 and 60 years. Exclusion Criteria: - BMI = 40 kg / m²; - history of stroke; - neuropathy or severe retinopathy; - any serious medical condition that prevents the participant to exercise safely; - history of severe physical disability - history of acute myocardial infarction in the last six months. |
| Country | Name | City | State |
|---|---|---|---|
| Brazil | Physical Education School of the Federal University of Pelotas | Pelotas | Rio Grande do Sul |
| Lead Sponsor | Collaborator |
|---|---|
| Federal University of Pelotas |
Brazil,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in HbA1c | - Glycated hemoglobin - % | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in Glucose | Fasting glucose - mg/dl | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in Insulin | Fasting insulin - µI/ml | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in BP | - Blood pressure - mm/hg measured with an automated equipment; | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in Insulin resistance | Insulin resistance - Insulin (µI/L) X Fasting Glycemia (mg/dl)/405 | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in Triglycerides | Triglycerides - mg/dl | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in Cholesterol | Total cholesterol and subfractions - mg/dl | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in CRP | C-reactive protein - mg/l | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in CRF | - Cardiorespiratory fitness - calculated based on the distance covered during the 6-minute walking test; | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in LLS | - Lower limb strength - number of repetitions performed during the 30-Second Chair Stand Test; | Measured at baseline, and the end of intervention, 12th week | |
| Secondary | Change in QoL | - Quality of life (SF-36) - sum of the scores of the scale. | Measured at baseline, and the end of intervention, 12th week |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |